L&G Pharma Breakthrough UCITS ETF (ETLI.DE) XETRA
11.28
-0.34(-2.93%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
11.28
-0.34(-2.93%)
Currency In EUR
| Market Cap | N/A |
| Enterprise Value | N/A |
| P/E Ratio | N/A |
| PEG Ratio | N/A |
| Price/Sales Ratio | N/A |
| Price/Book Ratio | N/A |
| Enterprise/Revenue | N/A |
| Enterprise/EBITDA | N/A |
| Fiscal Year | N/A |
| Most Recent Quarter | N/A |
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return On Assets | N/A |
| Return On Equity | N/A |
| Revenue | N/A |
| Revenue/Share | N/A |
| Gross Profit | N/A |
| EBITDA | N/A |
| Net Income | N/A |
| Diluted EPS | N/A |
| Total Cash | N/A |
| Total Cash/Share | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
| 52-Week Change | 20 |
| 52-Week High | 12.21 |
| 52-Week Low | 8.95 |
| Moving Average 50 Days | 11.77 |
| Moving Average 200 Days | 11.47 |
| Average Volume | 2,216 |
| Shares Outstanding | 1.38M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
| Last Split Date | N/A |